↓ Skip to main content

Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study

Overview of attention for article published in Diabetology & Metabolic Syndrome, April 2023
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Probiotics for glycemic and lipid profile control of the pre-diabetic patients: a randomized, double-blinded, placebo-controlled clinical trial study
Published in
Diabetology & Metabolic Syndrome, April 2023
DOI 10.1186/s13098-023-01050-9
Pubmed ID
Authors

Mina AkbariRad, Somayeh Sadat Shariatmaghani, Bibi Marjan Razavi, Hassan Mehrad Majd, Zeinab Shakhsemampour, Mehrdad Sarabi, Maryam Jafari, Setareh Azarkar, AmirAli Moodi Ghalibaf, Zahra Mazloum Khorasani

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 14%
Student > Ph. D. Student 1 5%
Unspecified 1 5%
Student > Postgraduate 1 5%
Other 1 5%
Other 0 0%
Unknown 14 67%
Readers by discipline Count As %
Medicine and Dentistry 3 14%
Unspecified 1 5%
Arts and Humanities 1 5%
Social Sciences 1 5%
Nursing and Health Professions 1 5%
Other 0 0%
Unknown 14 67%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 April 2023.
All research outputs
#20,994,646
of 23,628,742 outputs
Outputs from Diabetology & Metabolic Syndrome
#582
of 699 outputs
Outputs of similar age
#225,109
of 287,326 outputs
Outputs of similar age from Diabetology & Metabolic Syndrome
#19
of 26 outputs
Altmetric has tracked 23,628,742 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 699 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,326 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.